Spots Global Cancer Trial Database for gallbladder cancer
Every month we try and update this database with for gallbladder cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Gemcitabine and Capecitabine in Treating Patients With Advanced and/or Inoperable Cholangiocarcinoma or Carcinoma of the Gallbladder | NCT00084942 | Extrahepatic Bi... Gallbladder Can... | capecitabine gemcitabine hyd... | 18 Years - | Roswell Park Cancer Institute | |
| Interleukin-12 in Treating Patients With Cancer in the Abdomen | NCT00003046 | Anal Cancer Colorectal Canc... Gallbladder Can... Gastric Cancer Pancreatic Canc... | Recombinant Int... | 18 Years - | M.D. Anderson Cancer Center | |
| Quality Of Life in Patients With Malignant Biliary Obstruction | NCT00579865 | Gallbladder Can... Liver Cancer Bile Duct Cance... | questionnaires questionnaires | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Palonosetron Hydrochloride in Preventing Nausea and Vomiting Caused by Radiation Therapy in Patients With Primary Abdominal Cancer | NCT00903396 | Anal Cancer Carcinoma of th... Colorectal Canc... Extrahepatic Bi... Gallbladder Can... Gastric Cancer Gastrointestina... Liver Cancer Nausea and Vomi... Pancreatic Canc... Primary Periton... Small Intestine... | palonosetron hy... placebo | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Comprehensive Electronic Cancer Support System for the Treatment of Cancer Related Symptoms | NCT01640522 | Hepatocellular ... Primary Liver C... Bile Duct Cance... Pancreatic Canc... Gallbladder Can... Colorectal Carc... Liver Metastase... | Collaborative C... Enhanced usual ... | 18 Years - | University of Pittsburgh | |
| Comprehensive Electronic Cancer Support System for the Treatment of Cancer Related Symptoms | NCT01640522 | Hepatocellular ... Primary Liver C... Bile Duct Cance... Pancreatic Canc... Gallbladder Can... Colorectal Carc... Liver Metastase... | Collaborative C... Enhanced usual ... | 18 Years - | University of Pittsburgh | |
| Irinotecan and Capecitabine as Second-line Treatment for Advanced/Metastatic Biliary Tract Cancers | NCT02720601 | Biliary Tract C... | Irinotecan & Ca... | 18 Years - | New Mexico Cancer Care Alliance | |
| Interleukin-12 in Treating Patients With Cancer in the Abdomen | NCT00003046 | Anal Cancer Colorectal Canc... Gallbladder Can... Gastric Cancer Pancreatic Canc... | Recombinant Int... | 18 Years - | M.D. Anderson Cancer Center | |
| NGS in Gallbladder Cancer and Response to Treatment | NCT05404347 | Gallbladder Can... | Next generation... | 18 Years - 99 Years | Banaras Hindu University | |
| DX-8951f in Treating Patients With Biliary Cancer | NCT00005938 | Extrahepatic Bi... Gallbladder Can... Liver Cancer | exatecan mesyla... | 16 Years - | Daiichi Sankyo | |
| Radiation Therapy in Treating Patients With Bile Duct, Gallbladder, or Pancreatic Cancer | NCT00003411 | Extrahepatic Bi... Gallbladder Can... Pancreatic Canc... | motexafin gadol... radiation thera... | 18 Years - 120 Years | University of Pittsburgh | |
| Chemothetapy FORFIRINOX in Advanced or Recurrent Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma | NCT03772132 | Cholangiocarcin... Gallbladder Can... | mutation and si... | 18 Years - 80 Years | Shanghai Jiao Tong University School of Medicine | |
| UCAD for Diagnosing Benign or Malignant Gallbladder Diseases and Follow-up | NCT06232538 | Gallbladder Can... | The level of CN... | 18 Years - | Xinhua Hospital, Shanghai Jiao Tong University School of Medicine | |
| Adjuvant Palliative Capecitabine and Gemcitabine in Treating Patients With Locally Advanced or Metastatic Biliary Tract Cancer | NCT00073905 | Extrahepatic Bi... Gallbladder Can... Liver Cancer Pain | capecitabine pl... | 18 Years - 80 Years | Swiss Group for Clinical Cancer Research | |
| The Relationship Between Triceps Skinfold and Overall Survival of Pancreas, Bile Duct, Gallbladder Cancer | NCT03637569 | Pancreas Cancer Cholangiocarcin... Gallbladder Can... | Measurement of ... | 18 Years - | Samsung Medical Center | |
| Avastin and Tarceva for Upper Gastrointestinal Cancers | NCT00350753 | Cholangiocarcin... Gallbladder Can... | Erlotinib and b... | 18 Months - | Rigshospitalet, Denmark | |
| Oxaliplatin Plus Irinotecan in Treating Patients With Metastatic Gastrointestinal Cancer | NCT00003427 | Anal Cancer Colorectal Canc... Esophageal Canc... Extrahepatic Bi... Gallbladder Can... Gastric Cancer Gastrointestina... Liver Cancer Pancreatic Canc... Small Intestine... | irinotecan hydr... oxaliplatin | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Combination Chemotherapy in Treating Patients With Unresectable or Metastatic Biliary Tract or Gallbladder Cancer | NCT00009893 | Extrahepatic Bi... Gallbladder Can... Liver Cancer | fluorouracil gemcitabine hyd... leucovorin calc... | 18 Years - 120 Years | Alliance for Clinical Trials in Oncology | |
| S0202 Gemcitabine and Capecitabine for Unresectable Locally Advanced Metastatic Gallbladder Cancer or Cholangiocarcinoma | NCT00033540 | Extrahepatic Bi... Gallbladder Can... | capecitabine gemcitabine hyd... | 18 Years - | SWOG Cancer Research Network | |
| S0202 Gemcitabine and Capecitabine for Unresectable Locally Advanced Metastatic Gallbladder Cancer or Cholangiocarcinoma | NCT00033540 | Extrahepatic Bi... Gallbladder Can... | capecitabine gemcitabine hyd... | 18 Years - | SWOG Cancer Research Network | |
| S0809: Capecitabine, Gemcitabine, and RT in Patients w/Cholangiocarcinoma of the Gallbladder or Bile Duct | NCT00789958 | Extrahepatic Bi... Gallbladder Can... | capecitabine gemcitabine hyd... 3-dimensional c... intensity-modul... | 18 Years - 120 Years | SWOG Cancer Research Network | |
| Oxaliplatin, Gemcitabine, Erlotinib, and Radiation Therapy in Treating Patients With Unresectable and/or Metastatic Pancreatic Cancer or Biliary Tract Cancer | NCT00266097 | Extrahepatic Bi... Gallbladder Can... Pancreatic Canc... | erlotinib hydro... gemcitabine hyd... oxaliplatin radiation thera... gemcitabine hyd... Oxaliplatin | 18 Years - | UNC Lineberger Comprehensive Cancer Center | |
| Gemcitabine and Cisplatin With or Without CPI-613 as First Line Therapy for Patients With Advanced Unresectable Biliary Tract Cancer (BilT-04) | NCT04203160 | Biliary Tract C... | CPI 613 Gemcitabine Cisplatin | 18 Years - | University of Michigan Rogel Cancer Center | |
| Chile Biliary Longitudinal Study | NCT02692911 | Gallbladder Can... Nutritional and... | 50 Years - 74 Years | National Institutes of Health Clinical Center (CC) | ||
| The Role of Different Imaging Methods in the Diagnosis of Gallbladder Polyps | NCT02762227 | Polyp of Gallbl... | Abdominal high ... Contrast-enhanc... Cholecystectomy | 18 Years - 70 Years | RenJi Hospital | |
| Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy for Advanced HER2-positive Biliary Tract Cancer | NCT06282575 | Biliary Tract C... HER2 Gene Mutat... | Zanidatamab Cisplatin Gemcitabine Pembrolizumab Durvalumab | 18 Years - | Jazz Pharmaceuticals | |
| Palliative Biliary Stenting on the Quality of Life of Patients With Unresectable Carcinoma Gallbladder With Hiliar Block. | NCT00391183 | Gallbladder Can... | Biliary stentin... | 18 Years - 90 Years | All India Institute of Medical Sciences, New Delhi | |
| Gemcitabine and Radiation Therapy in Treating Patients With Locally Advanced Upper Gastrointestinal Cancer | NCT00544193 | Extrahepatic Bi... Gallbladder Can... Gastric Cancer Pancreatic Canc... Small Intestine... | gemcitabine hyd... polymerase chai... immunohistochem... conventional su... intraoperative ... radiation thera... | 18 Years - 70 Years | City of Hope Medical Center | |
| Adjuvant Chemotherapy vs no Chemotherapy for Patients With GallBllader Carcinoma | NCT02778308 | Gallbladder Can... | Gemcitabine + C... | 18 Years - 75 Years | Govind Ballabh Pant Institute of Postgraduate Medical Education and Research | |
| The PLATON Network | NCT05489250 | Hepatocellular ... Cholangiocarcin... Gallbladder Can... Pancreatic Canc... Oesophageal Can... Stomach Cancer | 18 Years - | Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest | ||
| Study of Gemcitabine and Carboplatin in the Treatment of Metastatic or Recurrent Cholangiocarcinoma/Gallbladder Cancer | NCT00660140 | Cholangiocarcin... Gallbladder Can... | Gemcitabine Carboplatin | 18 Years - | Washington University School of Medicine | |
| STALL vs Sole Local Wound Infiltration in Laparoscopic Cholecystectomy | NCT06123117 | Cholelithiasis Cholecystitis Gallbladder Can... | single transver... local trocar si... | 18 Years - | Helsinki University Central Hospital | |
| Vaccine Therapy in Treating Patients With Cancer of the Gastrointestinal Tract | NCT00012246 | Colorectal Canc... Esophageal Canc... Extrahepatic Bi... Gallbladder Can... Gastric Cancer Pancreatic Canc... Small Intestine... | carcinoembryoni... incomplete Freu... sargramostim | 18 Years - | The University of Texas Medical Branch, Galveston | |
| Feasibility Study of Multi-Platform Profiling of Resected Biliary Tract Cancer | NCT04561453 | Biliary Tract C... Cholangiocarcin... Gallbladder Can... Intrahepatic Ch... Perihilar Chola... Extrahepatic Ch... Hilar Cholangio... Distal Bile Duc... | Multi-Platform ... | 18 Years - | University of Washington | |
| Capecitabine or Observation After Surgery in Treating Patients With Biliary Tract Cancer | NCT00363584 | Extrahepatic Bi... Gallbladder Can... Liver Cancer | capecitabine clinical observ... adjuvant therap... | 18 Years - | National Cancer Institute (NCI) | |
| Psychological and Emotional Impact in Patients Undergoing Treatment For Metastatic Cancer Either in a Clinical Trial or as Standard Off-Trial Therapy | NCT00896467 | Anal Cancer Anxiety Disorde... Breast Cancer Depression Esophageal Canc... Gallbladder Can... Gastric Cancer Kidney Cancer Liver Cancer Lung Cancer Pancreatic Canc... Small Intestine... | questionnaire a... psychosocial as... quality-of-life... | 18 Years - | National Cancer Institute (NCI) | |
| Oxaliplatin, Gemcitabine, Erlotinib, and Radiation Therapy in Treating Patients With Unresectable and/or Metastatic Pancreatic Cancer or Biliary Tract Cancer | NCT00266097 | Extrahepatic Bi... Gallbladder Can... Pancreatic Canc... | erlotinib hydro... gemcitabine hyd... oxaliplatin radiation thera... gemcitabine hyd... Oxaliplatin | 18 Years - | UNC Lineberger Comprehensive Cancer Center | |
| Alcohol Consumption and Gallbladder Cancer | NCT02326948 | Gallbladder Can... | - | Cheju Halla General Hospital | ||
| Combination Therapy of HAIC, Surufatinib and Tislelizumab for Unresectable or Metastatic Biliary Tract Cancer | NCT06134193 | Carcinoma Intrahepatic Ch... Gallbladder Can... Surufatinib Angiogenesis In... Tislelizumab Antineoplastic ... Immunotherapy | HAIC Surufatinib Tislelizumab | 18 Years - 75 Years | Wuhan Union Hospital, China | |
| Adjuvant Immunotherapy Combined With Chemoradiation for Patients With High-risk reseCtable Extrahepatic chOlangiocaRcinoma and gallblaDder Cancer | NCT04333927 | Biliary Tract C... Extrahepatic Ch... Gallbladder Can... | Chemotherapy Observation Immunotherapy Radiotherapy | 18 Years - 70 Years | Sun Yat-sen University | |
| Evaluation of the Effectiveness of Intraoperative Frozen Section on the Treatment of Suspected Gallbladder Cancer | NCT06189664 | Gallbladder Can... | Frozen section | - | Imperial College London | |
| Construction of Multicenter Retrospective Registry Cohort Database for Gallbladder Cancer | NCT06276153 | Biliary Tract D... Gallbladder Can... Gallbladder Neo... | no intervention... | 18 Years - 74 Years | RenJi Hospital | |
| Addition of Everolimus to Standard of Care in Carcinoma Gallbladder | NCT05833815 | Gallbladder Can... | Everolimus 10 m... Standard of car... | 18 Years - 99 Years | Banaras Hindu University | |
| International Registry of Patients Treated With Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) | NCT03210298 | Peritoneum Canc... Peritoneum Neop... Pleural Cancer Pleural Effusio... Pleural Mesothe... Ovarian Cancer Gastric Cancer Appendix Cancer Pseudomyxoma Pe... Colorectal Canc... Pancreas Cancer Gallbladder Can... Ascites CUP Chemotherapeuti... | PIPAC | 10 Years - | University of Magdeburg | |
| International Registry of Patients Treated With Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) | NCT03210298 | Peritoneum Canc... Peritoneum Neop... Pleural Cancer Pleural Effusio... Pleural Mesothe... Ovarian Cancer Gastric Cancer Appendix Cancer Pseudomyxoma Pe... Colorectal Canc... Pancreas Cancer Gallbladder Can... Ascites CUP Chemotherapeuti... | PIPAC | 10 Years - | University of Magdeburg | |
| Visceral Lymphatic Mapping Using Isosulfan Blue in Patients With Cancer of the Pancreas, Colon, Stomach, Small Intestine, or Gallbladder | NCT00489515 | Colorectal Canc... Gallbladder Can... Gastric Cancer Pancreatic Canc... Small Intestine... | 18 Years - 120 Years | Wake Forest University Health Sciences | ||
| Toripalimab Plus Lenvatinib as Second-line Treatment in Advanced Biliary Tract Cancers | NCT04211168 | Advanced Biliar... | Toripalimab plu... | 18 Years - | Peking Union Medical College Hospital | |
| Capecitabine, Epirubicin, and Carboplatin in Treating Patients With Progressive, Unresectable, or Metastatic Cancer | NCT00486356 | Extrahepatic Bi... Gallbladder Can... Gastric Cancer Liver Cancer Unspecified Adu... | capecitabine carboplatin epirubicin hydr... microarray anal... polymorphism an... pharmacological... | 18 Years - 120 Years | University of Nebraska | |
| Pembrolizumab (MK-3475) Plus Gemcitabine/Cisplatin Versus Placebo Plus Gemcitabine/Cisplatin for First-Line Advanced and/or Unresectable Biliary Tract Carcinoma (BTC) (MK-3475-966/KEYNOTE-966)-China Extension Study | NCT04924062 | Biliary Tract C... | Pembrolizumab Gemcitabine Cisplatin Placebo | 18 Years - | Merck Sharp & Dohme LLC | |
| Observational Study on Patients With Hepatobiliary Tumors | NCT04637048 | Hepatocellular ... Cholangiocarcin... Gallbladder Can... Biliary Tract C... Gastric Cancer Colorectal Canc... | 18 Years - | First Affiliated Hospital of Wenzhou Medical University | ||
| Storage of Bile From Routine Procedures to Study Risk Factors | NCT00414843 | Gallbladder Can... Cholangiocarcin... Biliary Tract C... | 18 Years - | Indiana University | ||
| Biliary Stenting With or Without Photodynamic Therapy in Treating Patients With Locally Advanced, Recurrent, or Metastatic Cholangiocarcinoma or Other Biliary Tract Tumors That Cannot Be Removed by Surgery | NCT00513539 | Extrahepatic Bi... Gallbladder Can... | porfimer sodium biliary stentin... | 18 Years - | University College, London | |
| Endoscopic Versus Percutaneous Drainage For Hilar Block in Gall Bladder Cancer | NCT00409864 | Gallbladder Can... Obstructive Jau... | Endoscopic bili... | 18 Years - 80 Years | All India Institute of Medical Sciences, New Delhi | |
| Gemcitabine and Cisplatin for Gallbladder and Biliary Tract Cancer | NCT00123825 | Gallbladder Can... Biliary Tract C... | Gemcitabine Cisplatin | 18 Years - | Dana-Farber Cancer Institute | |
| STALL vs Sole Local Wound Infiltration in Laparoscopic Cholecystectomy | NCT06123117 | Cholelithiasis Cholecystitis Gallbladder Can... | single transver... local trocar si... | 18 Years - | Helsinki University Central Hospital | |
| T Cell Mediated Adaptive Therapy for Her2-positive Neoplasms of Digestive System | NCT02662348 | Esophageal Canc... Gastric Cancer Pancreatic Canc... Liver Cancer Gallbladder Can... Bowel Cancer | Recombinant Hum... HER2Bi-Armed T ... | 18 Years - 65 Years | The First Affiliated Hospital with Nanjing Medical University | |
| Vaccine Therapy in Treating Patients With Advanced or Metastatic Cancer | NCT00027534 | Breast Cancer Colorectal Canc... Gallbladder Can... Gastric Cancer Head and Neck C... Liver Cancer Ovarian Cancer Pancreatic Canc... Testicular Germ... | TRICOM-CEA(6D) | 18 Years - | Duke University | |
| Molecularly Target Therapy With GEMOX in Advanced or Recurrent Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma | NCT02836847 | Cholangiocarcin... Gallbladder Can... | biological test GEMOX Cetuximab Trastuzumab Gefitinib Lapatinib Everolimus Sorafenib Crizotinib | 18 Years - 80 Years | Shanghai Jiao Tong University School of Medicine | |
| Vaccine Therapy in Treating Patients With Cancer of the Gastrointestinal Tract | NCT00012246 | Colorectal Canc... Esophageal Canc... Extrahepatic Bi... Gallbladder Can... Gastric Cancer Pancreatic Canc... Small Intestine... | carcinoembryoni... incomplete Freu... sargramostim | 18 Years - | The University of Texas Medical Branch, Galveston | |
| Alcohol Consumption and Gallbladder Cancer | NCT02326948 | Gallbladder Can... | - | Cheju Halla General Hospital | ||
| Combination Chemotherapy in Treating Patients With Unresectable or Metastatic Biliary Tract or Gallbladder Cancer | NCT00009893 | Extrahepatic Bi... Gallbladder Can... Liver Cancer | fluorouracil gemcitabine hyd... leucovorin calc... | 18 Years - 120 Years | Alliance for Clinical Trials in Oncology | |
| Pembrolizumab in Biliary Tract Cancer | NCT03260712 | Biliary Tract C... Metastatic Canc... Advanced Cancer Gallbladder Can... | Pembrolizumab Cisplatin Gemcitabine | 18 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| The Construction of Clinical Database and Multiomics Biobank Based on a Multicentral Prospective Cohort of Benign and Malignant Biliary Tract Diseases | NCT05896956 | Biliary Tract D... Gallbladder Can... Extrahepatic Bi... Intrahepatic Ch... Biliary Tract N... Gall Stone | no intervention... | 18 Years - 74 Years | RenJi Hospital | |
| Study of TT-00420 (Tinengotinib) Tablet as Monotherapy and Combination Therapy in Patients With Advanced Solid Tumors | NCT04742959 | Advanced Solid ... Cholangiocarcin... HER2-negative B... Triple Negative... Bladder Cancer Small-cell Lung... Prostate Cancer Thyroid Cancer Sarcoma Gastric Cancer Gallbladder Can... | TT-00420 Nab-Paclitaxel | 18 Years - | TransThera Sciences (Nanjing), Inc. | |
| Capecitabine or Observation After Surgery in Treating Patients With Biliary Tract Cancer | NCT00363584 | Extrahepatic Bi... Gallbladder Can... Liver Cancer | capecitabine clinical observ... adjuvant therap... | 18 Years - | National Cancer Institute (NCI) | |
| ABC-08: Phase Ib Trial of Acelarin in Combination With Cisplatin in Locally Advanced/ Metastatic Biliary Tract Cancers | NCT02351765 | Biliary Tract C... Gallbladder Can... Cholangiocarcin... Ampullary Cance... | Acelarin Cisplatin | 18 Years - | The Christie NHS Foundation Trust | |
| Molecularly Target Therapy With FORFIRINOX in Advanced or Recurrent Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma | NCT03768375 | Cholangiocarcin... Gallbladder Can... | conventional ch... conventional ch... | 18 Years - 80 Years | Shanghai Jiao Tong University School of Medicine | |
| Gemcitabine, Oxaliplatin, Tarceva &/or Cisplatin in HCC & Biliary Tree Cancers | NCT00832637 | Hepatocellular ... Cholangiocellul... Cholangiocarcin... Bile Duct Cance... Periampullary A... Gallbladder Can... Extrahepatic Bi... | Cisplatin Erlotinib Gemcitabine | 18 Years - | New Mexico Cancer Care Alliance | |
| Adjuvant Palliative Capecitabine and Gemcitabine in Treating Patients With Locally Advanced or Metastatic Biliary Tract Cancer | NCT00073905 | Extrahepatic Bi... Gallbladder Can... Liver Cancer Pain | capecitabine pl... | 18 Years - 80 Years | Swiss Group for Clinical Cancer Research | |
| Liposomal Doxorubicin in Treating Patients With Liver or Bile Duct Cancer | NCT00003296 | Extrahepatic Bi... Gallbladder Can... Liver Cancer | filgrastim pegylated lipos... | 18 Years - | National Cancer Institute (NCI) | |
| Biliary Metal Stent Study: Metal Stents for Management of Distal Malignant Biliary Obstruction | NCT00280709 | Bile Duct Obstr... Pancreatic Canc... Gallbladder Can... Bile Duct Cance... | "Nitinella" ; S... | 20 Years - | University Hospital, Linkoeping | |
| Storage of Bile From Routine Procedures to Study Risk Factors | NCT00414843 | Gallbladder Can... Cholangiocarcin... Biliary Tract C... | 18 Years - | Indiana University | ||
| Quebec Pancreas Cancer Study | NCT04104230 | Pancreas Cancer Pancreatic Canc... Pancreas Neopla... Pancreas Cyst Pancreatic Prec... Familial Pancre... Hereditary Canc... Bile Duct Cance... Ampullary Cance... Duodenal Cancer Gallbladder Can... | 18 Years - | McGill University Health Centre/Research Institute of the McGill University Health Centre | ||
| Biomarker Discovery in Patients With Advanced Biliary Tract Cancer | NCT04871321 | Biliary Tract C... Cholangiocarcin... Gallbladder Can... | nab-paclitaxel ... | 19 Years - | CHA University | |
| Global Evaluation of Cholecystectomy Knowledge and Outcomes | NCT06223061 | Gallstone Gallbladder Can... Bile Duct Injur... | 18 Years - 100 Years | University of Edinburgh | ||
| A Study of LSTA1 When Added to Standard of Care Versus Standard of Care Alone in Patients With Advanced Solid Tumors | NCT05712356 | Cholangiocarcin... Gallbladder Can... Gallbladder Car... Intrahepatic Ch... Extrahepatic Ch... Bile Duct Cance... Gall Bladder Ca... Gall Bladder Ca... | LSTA1 Durvalumab Cisplatin Gemcitabine FOLFOX regimen Placebo | 18 Years - | Lisata Therapeutics, Inc. | |
| Pembrolizumab, a Monoclonal Antibody Against PD-1, in Combination With Capecitabine and Oxaliplatin (CAPOX) in People With Advanced Biliary Tract Carcinoma (BTC) | NCT03111732 | Biliary Tract N... Cholangiocarcin... Bile Duct Cance... Liver Cancer Gallbladder Can... | Pembrolizumab (... Oxaliplatin Capecitabine | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Gemcitabine With/Out Capecitabine in Locally Advanced, Unresectable, or Metastatic Biliary Cancer | NCT00658593 | Extrahepatic Bi... Gallbladder Can... Liver Cancer | capecitabine gemcitabine hyd... quality-of-life... | 18 Years - 120 Years | Canadian Cancer Trials Group | |
| The PLATON Network | NCT05489250 | Hepatocellular ... Cholangiocarcin... Gallbladder Can... Pancreatic Canc... Oesophageal Can... Stomach Cancer | 18 Years - | Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest | ||
| Gemcitabine With/Out Capecitabine in Locally Advanced, Unresectable, or Metastatic Biliary Cancer | NCT00658593 | Extrahepatic Bi... Gallbladder Can... Liver Cancer | capecitabine gemcitabine hyd... quality-of-life... | 18 Years - 120 Years | Canadian Cancer Trials Group |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
